| | | |  | | | | By Justin Chen Courtesy Stowers Institute Nectar bats push biology to the limit — making them “wonderful, majestic flying superheroes,” says scientist Jasmin Camacho. Read More | | By Adam Feuerstein STAT Higher costs borne by insurers will be passed on in the form of higher premiums, as one critic of the drug industry noted. Read More | | By Jonathan Wosen Biosplice The results show that the small-molecule drug lorecivivint failed to significantly soothe the pain of osteoarthritis patients. Read More | | Sponsored Insight by Sanofi From the lab to the real world: strides to help improve the lives of people with multiple myeloma Two decades ago, the median survival for people diagnosed with multiple myeloma was approximately three years. Now, people are surviving an average of eight to ten years thanks to the availability of newer, innovative therapies, which have transformed the treatment landscape and outlook for patients and families. Read the full Q&A with Peter Adamson, Global Head of Oncology Development & Pediatric Innovation at Sanofi. | | By Ed Silverman JOHN MACDOUGALL/AFP/Getty Images Overall, the aggregated sales of antibiotic used by veterinarians in 2021 indicated a 4.9% decrease compared to 2020. Read More | | By Thomas Newcomer Adobe Misperceptions of inferiority and the intricacies of the domestic market access are limiting biosimilar adoption in the U.S. Read More | | By Jonathan Wosen Christine Kao / STAT Some patients might need to produce high levels of a therapeutic protein for a prolonged period of time to benefit from an mRNA treatment. Read More | |
No comments